3057557-03-3
3057557-03-3
Chemical Structure
Allopole-A
- CAS No.: 3057557-03-3
- Formula:C11H9ClN4OS2
- Molecular Weight:312.80
InChIKey: ACSIYLGZFSSIBQ-UHFFFAOYSA-N
SMILES: S=C1NN=C(N1C2=C3SC(Cl)=C2)N(C3=O)CC4CC4
Biological Activity: Allopole-A is a Plk1 inhibitor with an IC50 of 1.4-2.5 μM against human Plk1 PBD1. Allopole-A binds to the allosteric W-F pocket in Plk1 PBD1, displacing the L2 loop, thereby disrupting water-mediated phospho-ligand binding interactions and promoting inhibitory interactions between the kinase domain and PBD to suppress Plk1 kinase activity. Allopole-A can be used in studies of human cancers with plk1 overexpression[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Allopole-A | Allopole-A is a Plk1 inhibitor with an IC50 of 1.4-2.5 μM against human Plk1 PBD1. Allopole-A binds to the allosteric W-F pocket in Plk1 PBD1, displacing the L2 loop, thereby disrupting water-mediated phospho-ligand binding interactions and promoting inhibitory interactions between the kinase domain and PBD to suppress Plk1 kinase activity. Allopole-A can be used in studies of human cancers with plk1 overexpression. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
